eMJA: Coeliac disease: to screen or not to screen, that is the question

Editorials

Coeliac disease: to screen or not to screen, that is the question

John M Duggan and Anne E Duggan

MJA 2009; 190 (8): 404-405

An appropriate strategy is to test patients with symptoms and signs attributable to coeliac disease

In recent years, knowledge about coeliac disease (CD) has improved significantly, and we now have a better understanding of the diagnosis and pathogenesis of the disease. In this issue of the Journal Chin and colleagues report the largest community study of CD undertaken in Australia.1 The study found a prevalence of CD of between 0.56% and 0.96%,1 similar to prevalences found in European population studies. A recent population-based serological study (without biopsy) in the United States found a prevalence of 0.95%.2

NB: If you are registered with the eMJA, your username is the email address you have provided.
If you don't have a login, click here for subscription options. You will be prompted to create an account upon purchase.

AMA members can login using their AMA username and password.
If you don't know your AMA password, please contact the AMA on 02 6270 5400 or membership@ama.com.au, or try to retrieve your password at this address.

The Medical Journal of Australia eMJA

Username:
Password:

Password forgotten? Click here What is my username?